HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Malin Wickström Selected Research

Neuroblastoma

11/2021PPM1D Is a Therapeutic Target in Childhood Neural Tumors.
1/2021Effects of PI3K and FGFR inhibitors alone and in combination, and with/without cytostatics in childhood neuroblastoma cell lines.
12/2019Analyses of FGFR3 and PIK3CA mutations in neuroblastomas and the effects of the corresponding inhibitors on neuroblastoma cell lines.
2/2019SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells in Vitro.
1/2019Neuroblastoma-A Neural Crest Derived Embryonal Malignancy.
1/2018Molecular mechanisms and therapeutic targets in neuroblastoma.
11/2017Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability in vitro and impairs tumor growth in vivo.
1/2017Rho-associated kinase is a therapeutic target in neuroblastoma.
3/2016Planar cell polarity gene expression correlates with tumor cell viability and prognostic outcome in neuroblastoma.
8/2014The impact of S6K1 kinase on neuroblastoma cell proliferation is independent of GLI1 signaling.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Malin Wickström Research Topics

Disease

30Neoplasms (Cancer)
04/2022 - 07/2003
16Neuroblastoma
11/2021 - 02/2007
6Medulloblastoma
04/2022 - 03/2014
3Breast Neoplasms (Breast Cancer)
12/2019 - 01/2008
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2019 - 08/2006
2Multiple Myeloma
09/2017 - 04/2016
2Leukemia
08/2013 - 07/2011
2Carcinoma (Carcinomatosis)
07/2011 - 01/2007
1Neoplasm Metastasis (Metastasis)
01/2020
1Urinary Bladder Neoplasms (Bladder Cancer)
12/2019
1Sarcoma (Soft Tissue Sarcoma)
12/2019
1Hypopituitarism (Sheehan's Syndrome)
05/2017
1Hyperkinesis
05/2017
1Cognitive Dysfunction
05/2017
1Hematologic Neoplasms (Hematological Malignancy)
04/2016
1Lymphoma (Lymphomas)
04/2016
1Adenocarcinoma
08/2014
1Lymphoid Leukemia
08/2013
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
03/2012
1Ovarian Neoplasms (Ovarian Cancer)
03/2012
1Hypoxia (Hypoxemia)
07/2011
1Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2010
1Colonic Neoplasms (Colon Cancer)
11/2009
1Colorectal Neoplasms (Colorectal Cancer)
11/2009
1Heart Diseases (Heart Disease)
11/2009

Drug/Important Bio-Agent (IBA)

10Pharmaceutical PreparationsIBA
12/2019 - 08/2006
6Proteins (Proteins, Gene)FDA Link
02/2019 - 12/2011
4Bortezomib (Velcade)FDA Link
03/2014 - 03/2007
3Phosphatidylinositols (Phosphatidylinositol)IBA
01/2020 - 12/2011
3rho-Associated KinasesIBA
12/2019 - 03/2016
3Biological ProductsIBA
01/2019 - 03/2009
3CD13 Antigens (Alanine Aminopeptidase)IBA
09/2017 - 03/2011
3Melphalan (Alkeran)FDA LinkGeneric
09/2017 - 09/2007
3CateninsIBA
03/2016 - 11/2015
2RNA (Ribonucleic Acid)IBA
04/2022 - 11/2017
2Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2020 - 12/2019
2Messenger RNA (mRNA)IBA
12/2019 - 08/2014
2Small Interfering RNA (siRNA)IBA
02/2019 - 03/2016
2Phosphotransferases (Kinase)IBA
11/2017 - 08/2014
2melflufenIBA
09/2017 - 04/2016
2Proteasome InhibitorsIBA
03/2014 - 03/2007
2Imatinib Mesylate (Gleevec)FDA Link
03/2012 - 03/2009
2Doxorubicin (Adriamycin)FDA LinkGeneric
03/2009 - 02/2007
2Simvastatin (Zocor)FDA LinkGeneric
10/2008 - 01/2008
2CholesterolIBA
10/2008 - 01/2008
2Thromboplastin (Tissue Factor)IBA
10/2008 - 01/2008
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2008 - 01/2008
2EnzymesIBA
02/2007 - 07/2003
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
04/2022
1Epoprostenol (Prostacyclin)FDA LinkGeneric
04/2022
1alpha-Linolenic Acid (Linolenic Acid)IBA
04/2022
1Dinoprostone (PGE2)FDA Link
04/2022
1SL-176IBA
11/2021
1nutlin 3IBA
11/2021
1Cytostatic AgentsIBA
01/2021
1RKI-1447IBA
12/2019
1NVP-BKM120IBA
12/2019
1dactolisibIBA
12/2019
1Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA
12/2019
1AZD4547IBA
12/2019
1Syk KinaseIBA
02/2019
1ChemokinesIBA
11/2017
1CytokinesIBA
11/2017
1CalciumIBA
11/2017
1AminopeptidasesIBA
09/2017
1LithiumIBA
05/2017
1Complementary DNA (cDNA)IBA
03/2016
1DNA Repair EnzymesIBA
11/2015
1Temozolomide (Temodar)FDA LinkGeneric
11/2015
1MethyltransferasesIBA
11/2015
1VLX40IBA
08/2013
1TubulinIBA
08/2013
1Vincristine (Oncovin)FDA LinkGeneric
08/2013
1Insulin-Like Growth Factor I (IGF-1)IBA
08/2013
1Insulin (Novolin)FDA Link
08/2013
1Cyclin D1IBA
04/2013
1cyclopamineIBA
04/2013
1GANT 61IBA
04/2013
1Cisplatin (Platino)FDA LinkGeneric
03/2012
1PI103IBA
12/2011
1IronIBA
07/2011
1CD 02750IBA
07/2011
1ChalconesIBA
04/2011
12,3- bis(2- hydroxyethylsulfanyl)- (1,4)naphthoquinoneIBA
01/2010
1Cytotoxins (Cytolysins)IBA
01/2010
1sanguinarineIBA
01/2010
1Brefeldin AIBA
01/2010
1DigitoxinFDA Link
11/2009
1convallatoxinIBA
11/2009
1Digoxin (Digitek)FDA LinkGeneric
11/2009
1oleandrinIBA
11/2009
1Cardiac GlycosidesIBA
11/2009
1ProscillaridinIBA
11/2009
1Becaplermin (PDGF-BB)FDA Link
03/2009

Therapy/Procedure

8Therapeutics
01/2021 - 03/2009
7Drug Therapy (Chemotherapy)
01/2021 - 07/2003
3Radiotherapy
01/2021 - 05/2017
1Immunotherapy
01/2021
1Stem Cell Transplantation
04/2016
1Injections
03/2014